Sam Murray

Immunologist, studying DPhil Clinical Medicine at Oxford University.

[Sam Murray @SamMurray13]

@SciImmunology @PKlenermanLab @nprovine @NDMOxford And please check out it's sister paper also at @SciImmunology, led by the brilliant @aliamini419 and @TheLucyGarner.

https://t.co/3l04daEUgZ

[Sam Murray @SamMurray13]

Very happy to share the latest work out in @SciImmunology. Here we use single cell RNA-sequencing in combination with an activation induced marker (AIM) assay to explore the impact of the COVID-19 vaccine regimen on T cell quality. With @PKlenermanLab @nprovine @NDMOxford

[Science Magazine @ScienceMagazine]

A new study finds that extended intervals between #SARSCoV2 mRNA vaccine doses lead to higher quality T cell responses and lower inflammation after vaccination in humans.

Learn more in @SciImmunology: https://t.co/jyHLazkXDK

[Science Immunology @SciImmunology]

Two new Science #Immunology studies provide insight into how different #COVID19 #vaccine types and dosing intervals affect T cell responses in humans.

📄: https://t.co/JayNtDUG56
📄: https://t.co/suNNHkKjtW

[Waggoner Lab @LabWaggoner]

MAIT and other innate-like T cells integrate adaptive immune responses to modulate interval-dependent reactogenicity to mRNA vaccines
https://t.co/E2O7V2AC54 @SciImmunology @PKlenermanLab @aliamini419 @TheLucyGarner @nprovine 🇬🇧

[Waggoner Lab @LabWaggoner]

Dosing interval is a major factor determining the quality of T cells induced by SARS-CoV-2 mRNA and adenoviral vector vaccines @SciImmunology @PKlenermanLab @nprovine 🇬🇧
https://t.co/eg07l1d5s8

[yEFIS @y_efis]

@SamMurray13 @UniofOxford
explained why some people don't respond to #mRNA #vaccines

[yEFIS @y_efis]

@nanaborsa @UniofOxford @miltenyibiotec @pintofscienceIE @tcddublin Great talks from #yEFIS immunologists 👏 🍻 🎉
@pintofscienceIE

[Megan Hanlon @MeganHanlon4]

Last chance to get limited tickets for our Pint of Immunology event at JR Mahon’s tomorrow night!! @Irishimmunology @EFIS_Immunology

[yEFIS @y_efis]

🎉 Join us in Dublin City Centre to hear from four top immunology #yefis young scientists explain their research over a pint! Expect pints, craic, trivia and learning about cutting edge research. 🧬🔬

📍Register here: https://t.co/RInPKocXIm.

[Megan Hanlon @MeganHanlon4]

Introducing ‘Pint of Immunology’🍻

Join us Sept 2nd for a night of #immunology & pints for a European Congress of Immunology 2024 public outreach event!

Open to all- get your free but limited tickets now https://t.co/AvMRyd82x7

Please RT and share! @Irishimmunology @tcdTBSI

[Pint of Science IE @pintofscienceIE]

Join us and @Irishimmunology at #ECI2024 for a night of talks with #immunology researchers @SamMurray13 @Diiind @nanaborsa and John McGrath🦠

🕢 Monday, September 2nd at 7.30pm
📍 @jrmahons, Dublin
���️ FREE (and limited!) tickets are on our site now! 👉 https://t.co/khBoAawWfU

[Sam Murray @SamMurray13]

Thanks very much! Really happy to have participated in such a great session!

[Sam Murray @SamMurray13]

Very excited to present in this session tomorrow morning amongst some leaders in the field! Come along to hear about our work to understand vaccine-related immune signatures in people with immunosuppressive conditions! #AAI2024

[The American Association of Immunologists (AAI) @ImmunologyAAI]

Don’t miss IMMUNOLOGY2024™’s first Major Symposium: Incorporating Time and Space into Multi-omic Systems Immunology Analyses tomorrow at 8 am in Skyline Ballroom W375C. #AAI2024

[Journal of Hepatology @JHepatology]

📢Check our January issue ‼️

Featured article:
➡️A prospective, multicenter, three-cohort study evaluating contrast-induced #acutekidneyinjury (CI-AKI) in patients with #cirrhosis
🔗https://t.co/tJ8uTe67ZO

Full issue👉https://t.co/QHvXVi5lG8

#LiverTwitter
@EASLnews
@EASLedu

[Journal of Hepatology @JHepatology]

🆕Article in press❕

Immune responses and clinical outcomes after COVID-19 vaccination in patients with #liverdisease and in #livertransplant recipients

Read it here👉https://t.co/krqP7WQXoV

@SamMurray13
@EleanorBarnesOx
@tom_marjot
#LiverTwitter

[pitchstudy @pitchstudy]

PITCH is proud to be a healthy control group for this very important and beautiful work on how liver patients across Europe respond to COVID vaccines

[The BMJ @bmj_latest]

What do we know about #covid in immunocompromised people?

Katharine Lang looks at the continuing dangers of covid for immunocompromised people, the treatments available to them, and how antivirals such as remdesivir may help
https://t.co/jhmRX8N50K

[Sam Murray @SamMurray13]

Really pleased to share this work, investigating immune responses to COVID-19 vaccines in people with liver diseases and liver transplants from across Europe.

A huge collaborative effort led by the expert @tom_marjot and @EleanorBarnesOx.

@JHepatology @EASLnews @NDM_Papers

[Tom Marjot @tom_marjot]

Delighted to see this out in @JHepatology

Immune responses & clinical outcomes across 3 #COVID vaccine doses. Includes longitudinal assessment of T cells & Ab in #cirrhosis, LT, AIH, VLD & HC

🔗https://t.co/bmMImtnoIt

Has been a privilege to work with such an amazing🌍 team👇

[Imperial Hepatology @IHepatology]

Now in @JHepatology from an international team (including @IHepatology members) - exploring immune responses and clinical outcomes after #COVID19 vaccination in patients with #liver disease and #OLT: https://t.co/8Yf4AzLk7r @tom_marjot @EleanorBarnesOx @bhmullish @penny_manousou

[GRAS Lab @GrasLab]

Extremely happy to share our latest work on #COVID-19 research identifying a genetic link with asymptomatic COVID infection.

How do people dodge #COVID?

https://t.co/rHkdb5Vl98

🧵below